GlassScriptPhysician profile
Robert Cranley
NPI 1770558058
$4,185.52
in general payments reported to CMS, 2019-2025
33 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,215 · 2020: $221 · 2021: $841 · 2022: $510 · 2023: $893 · 2024: $230 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $849.87 | 2019-2022 | |
| Smith+Nephew, INC. | $438.21 | 2019-2025 | Collagenase Santyl, Grafix, Oasis |
| Tactile Systems Technology INC | $355.80 | 2019-2024 | Flexitouch Plus, Entre Plus |
| W. L. Gore & Associates, INC. | $332.81 | 2019 | |
| Organogenesis INC. | $274.45 | 2019-2025 | Affinity, Puraply Wound Matrix, Puraply Am |
| Bsn Medical INC | $265.00 | 2023 | |
| Kci USA, INC. | $223.62 | 2019-2023 | Activ.A.C. |
| Lemaitre Vascular, INC. | $212.27 | 2021 | |
| Endologix LLC | $174.20 | 2019 | |
| Cook Medical LLC | $151.98 | 2022 | |
| Integra Lifesciences Corporation | $149.85 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Teleflex LLC | $119.92 | 2023 | Quikclot |
| Paratek Pharmaceuticals, INC. | $114.25 | 2019-2021 | |
| Pfizer INC. | $60.06 | 2019-2022 | |
| Shockwave Medical, INC | $36.29 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35.68 | 2025 | Endurant Iis |
| E.R. Squibb & Sons, L.L.C. | $35.45 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $33.85 | 2021 | |
| Solventum Corporation | $33.59 | 2024 | Activ.A.C. |
| Melinta Therapeutics, LLC | $31.90 | 2019 | |
| Ethicon US, LLC | $29.23 | 2019-2020 | |
| Polynovo North America LLC | $28.26 | 2023 | |
| Csl Behring | $26.96 | 2022 | |
| Covidien LP | $22.01 | 2019 | |
| Cvrx, INC. | $19.63 | 2024 | Barostim Neo System |
| Baxter Healthcare | $19.62 | 2019 | |
| Sanara Medtech INC. | $18.22 | 2023 | Celleraterx |
| Boston Scientific Corporation | $17.80 | 2023 | Spyglass Discover |
| Aroa Biosurgery Incorporated | $16.98 | 2020 | |
| Arjo INC. | $16.01 | 2025 | |
| Biocompatibles, INC. | $14.10 | 2019 | |
| Medline Industries LP | $13.86 | 2023 | Medline Industries, INC., Z-Guard |
| Terumo Medical Corporation | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cranley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.